The symptoms of Hurler syndrome--mental retardation, dwarfism, hearing loss, enlarged liver and spleen, and cardiac and respiratory problems--stem from deficiency of alpha-L-iduronidase, which normally breaks down glycosaminoglycans (a type of mucopolysaccharide) in the lysosomes of fibroblasts and white blood cells. Just a modest boost in enzyme production can lessen the severity of symptoms, but attempts at enzyme replacement therapy have failed. The researchers focused on Hurler syndrome because nearly two-thirds of the known mutations are nonsense. However, the investigators and others have also used the antibiotic to suppress nonsense mutations in cells from patients with cystic fibrosis,4 and in mice with muscular dystrophy.5 "This approach has tremendous potential. Aminoglycosides are just one type of antibiotic, and it works," says Bedwell. PTC Therapeutics of South Plainfield, NJ, is one step ahead--they are using high throughput assays to discover variations on the gentamicin theme that do not bring the side effects of ...
Antibiotic Corrects Genetic Glitch
Antibiotics that enable ribosomes to "read through" premature stop codons (nonsense mutations), which truncate proteins, may kick-start a new approach to gene therapy. A team of researchers from the University of Alabama at Birmingham and from the Women's and Children's Hospital in South Australia applied a long-ago observation about the antibiotic gentamicin on ribosomes to correct the enzyme deficiency that causes Hurler syndrome, in cultured fibroblasts from patients.1 The antibiotic apparent
Written byRicki Lewis
| 2 min read
Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share
Interested in reading more?
Become a Member of
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
